<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Valind K</submitter><funding>Medicinska Fakulteten, Lunds Universitet</funding><funding>Region Skåne</funding><funding>Knut och Alice Wallenbergs Stiftelse</funding><funding>Lund University</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Scintigraphy using technetium-99m labelled dimercaptosuccinic acid ([&lt;sup>99m&lt;/sup>Tc]Tc-DMSA), taken up in the proximal tubules, is the standard in functional imaging of the renal cortex. Recent guidelines recommend performing [&lt;sup>99m&lt;/sup>Tc]Tc-DMSA scintigraphy with single photon emission computed tomography (SPECT). Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) is used for staging and localization of recurrence in prostate cancer. A high renal uptake is often seen on PSMA PET, concordant with known PSMA expression in proximal tubules. This suggests PSMA PET could be used analogous to [&lt;sup>99m&lt;/sup>Tc]Tc-DMSA scintigraphy for renal cortical imaging. [&lt;sup>18&lt;/sup>F]PSMA-1007 is a promising radiopharmaceutical for this purpose</pubmed_abstract><journal>European journal of hybrid imaging</journal><pagination>25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10667166</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>[&lt;sup>18&lt;/sup>F]PSMA-1007 PET is comparable to [&lt;sup>99m&lt;/sup>Tc]Tc-DMSA SPECT for renal cortical imaging.</pubmed_title><pmcid>PMC10667166</pmcid><pubmed_authors>Valind K</pubmed_authors><pubmed_authors>Jogi J</pubmed_authors><pubmed_authors>Persson E</pubmed_authors><pubmed_authors>Minarik D</pubmed_authors><pubmed_authors>Garpered S</pubmed_authors><pubmed_authors>Tragardh E</pubmed_authors></additional><is_claimable>false</is_claimable><name>[&lt;sup>18&lt;/sup>F]PSMA-1007 PET is comparable to [&lt;sup>99m&lt;/sup>Tc]Tc-DMSA SPECT for renal cortical imaging.</name><description>&lt;h4>Background&lt;/h4>Scintigraphy using technetium-99m labelled dimercaptosuccinic acid ([&lt;sup>99m&lt;/sup>Tc]Tc-DMSA), taken up in the proximal tubules, is the standard in functional imaging of the renal cortex. Recent guidelines recommend performing [&lt;sup>99m&lt;/sup>Tc]Tc-DMSA scintigraphy with single photon emission computed tomography (SPECT). Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) is used for staging and localization of recurrence in prostate cancer. A high renal uptake is often seen on PSMA PET, concordant with known PSMA expression in proximal tubules. This suggests PSMA PET could be used analogous to [&lt;sup>99m&lt;/sup>Tc]Tc-DMSA scintigraphy for renal cortical imaging. [&lt;sup>18&lt;/sup>F]PSMA-1007 is a promising radiopharmaceutical for this purpose</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-21T21:06:01.345Z</modification><creation>2025-02-18T23:30:40.102Z</creation></dates><accession>S-EPMC10667166</accession><cross_references><pubmed>37996712</pubmed><doi>10.1186/s41824-023-00185-2</doi></cross_references></HashMap>